Production (Stage)
Corvus Pharmaceuticals, Inc.
CRVS
$3.49
$0.020.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.92% | 24.76% | -11.84% | 113.51% | -18.49% |
| Total Receivables | 5.09% | -2.26% | 81.15% | 110.34% | -7.94% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.87% | 21.13% | -23.02% | 104.05% | -34.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -68.98% | 165.81% | 71.24% | -7.66% | 13.28% |
| Total Current Assets | -16.39% | 26.76% | -11.06% | 111.19% | -18.26% |
|
|
|||||
| Total Current Assets | -16.39% | 26.76% | -11.06% | 111.19% | -18.26% |
| Net Property, Plant & Equipment | -5.12% | 191.87% | -40.91% | -28.57% | -22.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.47% | 150.79% | 95.35% | 44.94% | 0.00% |
| Total Assets | -13.74% | 17.16% | -8.90% | 61.06% | -12.01% |
|
|
|||||
| Total Accounts Payable | -49.34% | 37.85% | 54.41% | -24.61% | 5.51% |
| Total Accrued Expenses | 4.05% | -9.89% | -6.41% | 4.68% | 4.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 72.43% | -47.74% | -49.43% | -32.69% | -24.31% |
| Total Finance Division Other Current Liabilities | -86.04% | -27.66% | 449.35% | 4,005.03% | -26.94% |
| Total Other Current Liabilities | -86.04% | -27.66% | 449.35% | 4,005.03% | -26.94% |
| Total Current Liabilities | -73.79% | -23.71% | 248.00% | 98.44% | -2.17% |
|
|
|||||
| Total Current Liabilities | -73.79% | -23.71% | 248.00% | 98.44% | -2.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -10.99% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -72.17% | -21.69% | 248.00% | 98.44% | -2.17% |
|
|
|||||
| Common Stock & APIC | 0.36% | 8.25% | 0.20% | 5.92% | 0.18% |
| Retained Earnings | 3.83% | -3.15% | -11.67% | -1.25% | -1.70% |
| Treasury Stock & Other | 2.64% | -74.53% | 45.54% | -6.27% | -31.85% |
| Total Common Equity | 51.45% | 162.45% | -75.78% | 53.54% | -13.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.45% | 162.45% | -75.78% | 53.54% | -13.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 51.45% | 162.45% | -75.78% | 53.54% | -13.75% |
|
|
|||||